|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2007-4-5
|
|
pubmed:abstractText |
This prospective trial was conducted to evaluate the role of gefitinib in never-smokers with advanced or metastatic adenocarcinoma of the lung.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1556-1380
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
1
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
965-71
|
|
pubmed:dateRevised |
2008-5-6
|
|
pubmed:meshHeading |
pubmed-meshheading:17409980-Adenocarcinoma,
pubmed-meshheading:17409980-Administration, Oral,
pubmed-meshheading:17409980-Aged,
pubmed-meshheading:17409980-Biopsy, Needle,
pubmed-meshheading:17409980-Dose-Response Relationship, Drug,
pubmed-meshheading:17409980-Drug Administration Schedule,
pubmed-meshheading:17409980-Female,
pubmed-meshheading:17409980-Follow-Up Studies,
pubmed-meshheading:17409980-Humans,
pubmed-meshheading:17409980-Immunohistochemistry,
pubmed-meshheading:17409980-Korea,
pubmed-meshheading:17409980-Lung Neoplasms,
pubmed-meshheading:17409980-Male,
pubmed-meshheading:17409980-Middle Aged,
pubmed-meshheading:17409980-Multivariate Analysis,
pubmed-meshheading:17409980-Neoplasm Invasiveness,
pubmed-meshheading:17409980-Neoplasm Staging,
pubmed-meshheading:17409980-Probability,
pubmed-meshheading:17409980-Prognosis,
pubmed-meshheading:17409980-Proportional Hazards Models,
pubmed-meshheading:17409980-Prospective Studies,
pubmed-meshheading:17409980-Quality of Life,
pubmed-meshheading:17409980-Quinazolines,
pubmed-meshheading:17409980-Risk Assessment,
pubmed-meshheading:17409980-Single-Blind Method,
pubmed-meshheading:17409980-Smoking,
pubmed-meshheading:17409980-Survival Rate,
pubmed-meshheading:17409980-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
The role of gefitinib treatment for Korean never-smokers with advanced or metastatic adenocarcinoma of the lung: a prospective study.
|
|
pubmed:affiliation |
Research Institute and Hospital, Research Institute for National Cancer Control and Evaluation, Gyeonggi, Korea.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
